Patent 11053507 was granted and assigned to Inscripta on July, 2021 by the United States Patent and Trademark Office.
The present disclosure provides automated multi-module instrumentation and automated methods for performing recursive editing of live cells with curing of editing vectors from prior rounds of editing.